3-(4-三氟甲基 苯基)-1-丙醇 | 180635-74-9

• 物质功能分类: 分析化学 - 标准品 - 药典标准品和杂质标准品
• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 中文名称: 3-(4-三氟甲基 苯基)-1-丙醇
• 中文别名: 3-(4-三氟甲基苯基)-1-丙醇；4-三氟甲基苯丙醇
• 英文名称: 3-(4-(trifluoromethyl)phenyl)propan-1-ol
• 英文别名: 3-(4-trifluoromethylphenyl)-1-propanol；3-[4-(trifluoromethyl)phenyl]propan-1-ol
• CAS: 180635-74-9
• 化学式: C₁₀H₁₁F₃O
• 分子量: 204.192
• InChiKey: RDCHJYSYGXHSQF-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  2.7
• 重原子数：
  14
• 可旋转键数：
  3
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.4
• 拓扑面积：
  20.2
• 氢给体数：
  1
• 氢受体数：
  4

安全信息

• 海关编码：
  2906299090
• 危险性防范说明：
  P261,P280,P301+P312,P302+P352,P305+P351+P338
• 危险性描述：
  H302,H315,H319,H335

SDS

Material Safety Data Sheet

---

Section 1. Identification of the substance
Product Name: 3-[4-(trifluoromethyl)phenyl]propanol
Synonyms:

---

Section 2. Hazards identification
Harmful by inhalation, in contact with skin, and if swallowed.

---

Section 3. Composition/information on ingredients.
Ingredient name: 3-[4-(trifluoromethyl)phenyl]propanol
CAS number: 180635-74-9

---

Section 4. First aid measures
Skin contact: Immediately wash skin with copious amounts of water for at least 15 minutes while removing
contaminated clothing and shoes. If irritation persists, seek medical attention.
Eye contact: Immediately wash skin with copious amounts of water for at least 15 minutes. Assure adequate
flushing of the eyes by separating the eyelids with fingers. If irritation persists, seek medical
attention.
Inhalation: Remove to fresh air. In severe cases or if symptoms persist, seek medical attention.
Ingestion: Wash out mouth with copious amounts of water for at least 15 minutes. Seek medical attention.

---

Section 5. Fire fighting measures
In the event of a fire involving this material, alone or in combination with other materials, use dry
powder or carbon dioxide extinguishers. Protective clothing and self-contained breathing apparatus
should be worn.

---

Section 6. Accidental release measures
Personal precautions: Wear suitable personal protective equipment which performs satisfactorily and meets local/state/national
standards.
Respiratory precaution: Wear approved mask/respirator
Hand precaution: Wear suitable gloves/gauntlets
Skin protection: Wear suitable protective clothing
Eye protection: Wear suitable eye protection
Methods for cleaning up: Mix with sand or similar inert absorbent material, sweep up and keep in a tightly closed container
for disposal. See section 12.
Environmental precautions: Do not allow material to enter drains or water courses.

---

Section 7. Handling and storage
Handling: This product should be handled only by, or under the close supervision of, those properly qualified
in the handling and use of potentially hazardous chemicals, who should take into account the fire,
health and chemical hazard data given on this sheet.
Store in closed vessels.
Storage:

---

Section 8. Exposure Controls / Personal protection
Engineering Controls: Use only in a chemical fume hood.
Personal protective equipment: Wear laboratory clothing, chemical-resistant gloves and safety goggles.
General hydiene measures: Wash thoroughly after handling. Wash contaminated clothing before reuse.

---

Section 9. Physical and chemical properties
Appearance: Not specified
Boiling point: No data
No data
Melting point:
Flash point: No data
Density: No data
Molecular formula: C10H11F3O
Molecular weight: 204.2

---

Section 10. Stability and reactivity
Conditions to avoid: Heat, flames and sparks.
Materials to avoid: Oxidizing agents.
Possible hazardous combustion products: Carbon monoxide, hydrogen fluoride.

---

Section 11. Toxicological information
No data.

---

Section 12. Ecological information
No data.

---

Section 13. Disposal consideration
Arrange disposal as special waste, by licensed disposal company, in consultation with local waste
disposal authority, in accordance with national and regional regulations.

---

Section 14. Transportation information
Non-harzardous for air and ground transportation.

---

Section 15. Regulatory information
No chemicals in this material are subject to the reporting requirements of SARA Title III, Section
302, or have known CAS numbers that exceed the threshold reporting levels established by SARA
Title III, Section 313.

---

SECTION 16 - ADDITIONAL INFORMATION
N/A

反应信息

• 作为反应物：
  描述：

  3-(4-三氟甲基 苯基)-1-丙醇 在 四溴化碳 、 三苯基膦 作用下， 以 二氯甲烷 为溶剂， 反应 4.0h， 以1.0 g的产率得到1-溴-3-[4-(三氟甲基)苯基]丙烷
  参考文献：
  名称：

  空气稳定的 PdI 二聚体实现远程功能化：以前所未有的速度获得氟化 1,1-二芳基烷烃

  摘要：

  我们报告了在室温下在不到 10 分钟的反应时间内在长达 11 个碳的距离上进行的远程芳基化。空气稳定的 Pd 二聚体 [Pd(μ-I)(PCy 2 t Bu)] 2实现了前所未有的速度。

  DOI：

  10.1002/anie.202113667
• 作为产物：
  描述：

  3-(4-叔丁基苯)-丙酸 在 sodium tetrahydroborate 、 碘 作用下， 以 四氢呋喃 为溶剂， 反应 16.5h， 以100%的产率得到3-(4-三氟甲基 苯基)-1-丙醇
  参考文献：
  名称：

  [EN] SPHINGOSINE KINASE INHIBITORS
  [FR] INHIBITEURS DE LA SPHINGOSINE KINASE

  摘要：

  鞘氨醇激酶是催化鞘氨醇-1-磷酸酯生物合成的酶。该发明提供了对鞘氨醇激酶1型、鞘氨醇激酶2型或两者均具有效抑制作用的化合物。某些化合物相对于鞘氨醇激酶1型具有选择性作用于鞘氨醇激酶2型。该发明的化合物可用于治疗一系列疾病，其中增加血液中鞘氨醇-1-磷酸酯水平在医学上是指示的。通过给予该发明的化合物有效剂量可以治疗的疾病包括涉及过度血管生长的肿瘤性疾病；黄斑变性或糖尿病视网膜病变；哮喘等过敏性疾病，眼部炎症性疾病如葡萄膜炎、巩膜炎或玻璃体炎；肾脏炎症性疾病；纤维化疾病；动脉粥样硬化；或肺动脉高压。该发明的化合物可用于改善血管屏障的完整性，在血管屏障受损的疾病中，如癌症或阿尔茨海默病。

  公开号：

  WO2016054261A1
• 作为试剂：
  描述：

  硼烷 、 3-(4-三氟甲基苯基)丙酸 在 3-(4-三氟甲基 苯基)-1-丙醇 作用下， 生成 3-(4-三氟甲基 苯基)-1-丙醇
  参考文献：
  名称：

  5,6,7,8-TETRAHYDRO-IMIDAZO[1,5-A]PYRAZINE COMPOUNDS

  摘要：

  本发明涉及公式（I）的5,6,7,8-四氢咪唑[1,5-a]吡嗪衍生物，其中R1、R2、R3和R4如描述中所述，以及其盐，特别是药学上可接受的盐，以及将这些化合物用作药物，特别是作为促进睡眠的药物。

  公开号：

  US20110105514A1

文献信息

• Difluoromethylation of alcohols with TMSCF2Br in water: A new insight into the generation and reactions of difluorocarbene in a two-phase system
  作者：Rongyi Zhang、Chuanfa Ni、Qiqiang Xie、Jinbo Hu

  DOI：10.1016/j.tet.2020.131676

  日期：2020.12

  ved reactions can be performed in the presence of water, the reaction of difluorocarbene using water as the only reaction medium is rare. By using TMSCF2Br as a unique difluorocarbene reagent and KHF2 as a mild activator, the difluoromethylation of liquid alcohols in water is described. This research not only develops an environmentally benign process for the synthesis of difluoromethyl ethers, but

  尽管可以在水的存在下进行许多涉及二氟卡宾的反应，但是使用水作为唯一反应介质的二氟卡宾的反应很少。通过使用TMSCF 2 Br作为独特的二氟卡宾试剂和KHF 2作为温和的活化剂，描述了液体醇在水中的二氟甲基化。这项研究不仅为二氟甲基醚的合成开发了一种环境友好的方法，而且为油水两相系统中二氟卡宾的生成和反应提供了新的见识。
• Enhanced Structural Variety of Nonplanar <i>N</i>-Oxyl Radical Catalysts and Their Application to the Aerobic Oxidation of Benzylic C–H Bonds
  作者：Yoichi Kadoh、Kounosuke Oisaki、Motomu Kanai

  DOI：10.1248/cpb.c16-00083

  日期：——

  higher yields than a corresponding methoxy-substituted analogue. The introduction of substituents at the aromatic ring was also effective, as evident from the performance of 7-CF3 and 4,5,6,7-tetrafluoro precatalysts. Especially the combination of trifluoroethoxy- and 4,5,6,7-tetrafluoro substitution afforded a superior performance. These catalyst systems exhibited high functional group tolerance during

  描述了结构可变的非平面N-氧基自由基催化剂的设计与合成及其在苄基CH键的好氧氧化，醚化和乙酰氨基化中的应用。CH键的催化氧化代表了一种以直接方式从简单的烃类合成氧化功能分子的强大工具。由N-羟基邻苯二甲酰亚胺（1）生成的缺乏电子的N-氧基自由基催化剂，例如邻苯二甲酰亚胺N-氧基（PINO）自由基，由于其在高键解离能的CH键氧化中的应用而备受关注。 ）。然而，1中的几个位点可用于结构修饰和催化性能的改善。通过用三氟甲基（CF3）取代的sp（3）-碳取代1中的一个羰基，我们生成了一个额外的可调位点和一个非平面骨架，同时保留了所需的吸电子性能并提高了相对于1的亲脂性。我们合成了多种含有此类 部分的N-羟基预催化剂，并研究了它们在好氧环境中的效用。苄基CH键的氧化。具有吸电子取代基的预催化剂，例如三氟乙氧基和苯乙酮部分，比相应的甲氧基取代的类似物具有更高的产率。从7- 和4,5,6,7-四
• <i>N</i>-Hydroxyphthalimide-catalyzed chemoselective intermolecular benzylic C–H amination of unprotected arylalkanols
  作者：Masatoshi Shibuya、Takayuki Orihashi、Yamei Li、Yoshihiko Yamamoto

  DOI：10.1039/d1cc03466a

  日期：——

  N-Hydroxyphthalimide-catalyzed chemoselective benzylic C(sp3)–H amination of unprotected arylalkanols using bis(2,2,2-trichloroethyl)azodicarboxylate has been developed. The use of 1,1,1,3,3,3-hexafluoropropan-2-ol as a solvent plays a critical role in chemoselectivity. The conversion of an aminated product to the corresponding free amino alcohol was also demonstrated.

  N-羟基邻苯二甲酰亚胺催化的化学选择性苄基 C(sp 3 )-H 使用双 (2,2,2-三氯乙基) 偶氮二羧酸酯对未保护的芳基烷醇进行胺化。使用 1,1,1,3,3,3-六氟丙-2-醇作为溶剂在化学选择性中起着关键作用。还证明了胺化产物向相应游离氨基醇的转化。
• [EN] DIHYDROPYRAZOLOPYRIMIDINONE COMPOUNDS AS PDE2 INHIBITORS<br/>[FR] COMPOSÉS DIHYDROPYRAZOLOPYRIMIDINONE UTILISÉS EN TANT QU'EN TANT QU'INHIBITEURS DE PDE2
  申请人：MERCK SHARP & DOHME

  公开号：WO2016192083A1

  公开（公告）日：2016-12-08

  The present invention is directed to dihydropyrazolopyrimidinonecompounds of formula (I) which are useful as therapeutic agents for the treatment of central nervous system disorders associated with phosphodiesterase 2 (PDE2). The present invention also relates to the use of such compounds for treating neurological and psychiatric disorders, such as schizophrenia, psychosis, Parkinson's disease, Parkinson's disease dementia (PDD), or Huntington's disease, and those associated with striatal hypofunction or basal ganglia dysfunction.

  本发明涉及式(I)的二氢吡唑并嘧啶酮化合物，该化合物作为治疗与磷酸二酯酶2 (PDE2)相关的中枢神经系统障碍的治疗剂是有用的。本发明还涉及使用这些化合物来治疗神经和精神障碍，如精神分裂症、精神病、帕金森病、帕金森病痴呆（PDD）或亨廷顿病，以及与纹状体功能减退或基底神经节功能障碍相关的疾病。
• [EN] DITERPENOID COMPOUNDS THAT ACT ON PROTEIN KINASE C (PKC)<br/>[FR] COMPOSÉS DITERPÉNOÏDES AGISSANT SUR LA PROTÉINE KINASE C (PKC)
  申请人：K GEN INC

  公开号：WO2021062030A1

  公开（公告）日：2021-04-01

  This present disclosure relates to protein kinase C (PKC) modulating compounds, methods of treating a subject with cancer using the compounds, and combination treatments with a second therapeutic agent.

  本公开涉及蛋白激酶C（PKC）调节化合物，使用这些化合物治疗癌症患者的方法，以及与第二治疗剂联合治疗的方法。